ReviewImmunity, inflammation and disease2021

Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review.

Sara Manti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.